Search Results

Zeria expects to begin to market Veltassa ® following National Health Insurance price listing.

https://newsroom.csl.com/2024-09-24-Veltassa-R-patiromer-approved-in-Japan-for-the-treatment-of-adults-with-hyperkalemia

ToVs which are part of the ordinary course of purchase and sale of medicinal products, such as discounts, price reductions and other trading devices

https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-template-2024_final.pdf